AML

Jumio Wins Double Gold in the 10th Annual 2022 CEO World Awards®

Retrieved on: 
Tuesday, October 4, 2022
Online Privacy, Technology, Security, Software, Biometrics, Internet, Health, Data Management, Artificial Intelligence, Solution, Trust, Internet, KYC, Go to market, Fraud, Marketing, Central, Industry, CEO, Multimedia, Automation, Chief executive officer, Woman, Organization, AML, Gold, Globe Award, Information technology, Swedish Business Awards, 2002 FIFA World Cup qualification – CONCACAF Caribbean/Central American Play-offs, Leadership, Machine learning, GDPR, Technology, AI, IPRA Golden World Awards, Cryptocurrency, Jumio

Jumio, the leading provider of orchestrated end-to-end identity proofing, eKYC and AML solutions, today announced that it was named a gold winner for Company of the Year: Cyber Security Products and Company of the Year: Technology (All) in the 10th annual 2022 CEO World Awards.

Key Points: 
  • Jumio, the leading provider of orchestrated end-to-end identity proofing, eKYC and AML solutions, today announced that it was named a gold winner for Company of the Year: Cyber Security Products and Company of the Year: Technology (All) in the 10th annual 2022 CEO World Awards.
  • View the full release here: https://www.businesswire.com/news/home/20221004005175/en/
    Jumio Wins Double Gold in the 10th Annual 2022 CEO World Awards (Graphic: Business Wire)
    Jumio was honored for its KYX Platform , a unified identity verification, eKYC and AML platform that enables leading organizations to accurately establish, maintain and reassert customer trust from account opening to ongoing monitoring.
  • The coveted annual CEO World Awards program encompasses the worlds best in leadership, innovation, organizational performance, new products and services, excellence studies, corporate social responsibility, and milestones from every major industry in the world.
  • Globee Awards are conferred in nine programs and competitions: the American Best in Business Awards, Business Excellence Awards, CEO World Awards, Cyber Security Global Excellence Awards, Disruptor Company Awards, Golden Bridge Awards, Information Technology World Awards, Sales, Marketing, Service, & Operations Excellence Awards, and Women World Awards.

Matrixport secures USD 50M Insurance Coverage for Digital Assets Held with Cactus Custody from Canopius

Retrieved on: 
Tuesday, October 4, 2022
Solution, Mining, OTC, Theft, Non-fungible token, Ecosystem, MMI, BTC, Multimedia, AML, Cold, Lloyd's of London, COO, Insurance, XEC, LTC, Policy, USD, ETH, Risk, NFT, Financial services, Cryptocurrency, BCH

SINGAPORE, Oct. 3, 2022 /PRNewswire/ -- Matrixport, one of the world's largest digital assets financial services ecosystem, has announced the securing of USD 50 million of insurance coverage for digital assets[1] held in cold storage with Cactus Custody™, its institutional custodian. In addition to enjoying additional insurance coverage, clients have the assurance of the group having passed and met the due diligence standards to be insured by one of the world's largest crypto insurers.

Key Points: 
  • Cynthia Wu, COO of Matrixport, said: "We are glad to announce this insurance coverage by Canopius , one of the largest Lloyd's of London syndicates.
  • Client's asset security is the top priority for Cactus Custody, a qualified custodian, and Matrixport, a crypto financial institution.
  • The insurance coverage enhances our custody offerings and empowers clients to leverage our ecosystem in a meaningful way, especially for institutional clients where insurance coverage is a compulsory requirement.
  • Matrixport's existing institutional-grade custody services by Cactus Custody provides Warm & Cold digital asset storage solutions where funds and digital assets under custody are safeguarded through cutting-edge system security design and vault infrastructure built across 3 continents.

Matrixport secures USD 50M Insurance Coverage for Digital Assets Held with Cactus Custody from Canopius

Retrieved on: 
Tuesday, October 4, 2022
Solution, Mining, OTC, Theft, Non-fungible token, Ecosystem, MMI, BTC, AML, Cold, Lloyd's of London, COO, Insurance, XEC, LTC, Policy, USD, ETH, Risk, NFT, Financial services, Cryptocurrency, BCH

SINGAPORE, Oct. 4, 2022 /PRNewswire/ -- Matrixport, one of the world's largest digital assets financial services ecosystem, has announced the securing of USD 50 million of insurance coverage for digital assets[1] held in cold storage with Cactus Custody™, its institutional custodian. In addition to enjoying additional insurance coverage, clients have the assurance of the group having passed and met the due diligence standards to be insured by one of the world's largest crypto insurers.

Key Points: 
  • Client's asset security is the top priority for Cactus Custody, a qualified custodian, and Matrixport, a crypto financial institution.
  • The insurance coverage enhances our custody offerings and empowers clients to leverage our ecosystem in a meaningful way, especially for institutional clients where insurance coverage is a compulsory requirement.
  • Matrixport's existing institutional-grade custody services by Cactus Custody provides Warm & Cold digital asset storage solutions where funds and digital assets under custody are safeguarded through cutting-edge system security design and vault infrastructure built across 3 continents.
  • [1] "digital assets" - tokens covered under the policy include "BTC, BCH, XEC, LTC, ETH, all supportedERC20 tokens and NFT by Cactus Custody and Matrixport

Swifty Global Gets Swifty Gaming Off to a Flying Start and Updates its Annual Revenue Target

Retrieved on: 
Monday, October 3, 2022
Solution, KYC, Marketing, OTC, Time, Documentation, LinkedIn, Twitter, AML, Gambling, Cricket World Cup, Knowledge, Artificial intelligence, Association football, FIFA, Sport, Acquisition, United Kingdom, Financial technology, GLOBE, Cryptocurrency, Online gambling, Swifty

Swifty has successfully launched Swifty Gaming which has been well received by our growing international client base.

Key Points: 
  • Swifty has successfully launched Swifty Gaming which has been well received by our growing international client base.
  • During the month of September, Swifty Gaming generated $3.5 million revenue; this is a small percentage of our current network client database.
  • Swifty forecasts to double its monthly revenue to $7 million by December 2022.
  • For regular updates, you are invited you to follow Swifty Global on Twitter and LinkedIn.

DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY

Retrieved on: 
Monday, October 3, 2022
Chronic myelomonocytic leukemia, Association, Translational research, CLL, Lymphoma, TET2, RHOA, JCA, Research, Myelodysplastic syndrome, Disease, Lymphatic system, SF, AML, Infection, Chronic lymphocytic leukemia, Japanese Cancer Association, CHF, Acute myeloid leukemia, Medicine, Oncogene, Dasatinib, Safety, RNA, Patient, General Medicine Faculty of RostGMU (Rostov State Medical University), IDH, Isocitrate dehydrogenase, MDS, University, CMML, Pharmaceutical industry, Debiopharm

LAUSANNE, Switzerland , Oct. 3, 2022 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of JCA Mauvernay Award for breakthrough Japanese oncology research projects in 2 categories: Innovative and/or Disruptive Research – Dr. Akihide Yoshimi and for Translational Research – Prof. Mamiko Sakata-Yanagimoto. The winners were honored with trophies and a monetary prize during the live event of the 81st Annual Meeting of the Japanese Cancer Association (JCA) on Saturday, October 1st in Yokohama, Japan by Prof. Hideyuki Saya President of the JCA and Thierry Mauvernay, President of Debiopharm, and Bertrand Ducrey CEO of Debiopharm. 

Key Points: 
  • "The previous winners of the Mauvernay Award have immediately becomevery well-known scientists in our country, becoming professors and leaders in significant institutes.
  • Therefore, I would say that the Mauvernay Award is definitely a huge step for young cancer research scientists in our country."
  • Dr. Akihide Yoshimi's disruptive research at the National Cancer Center Research Institute, is aimed at understanding and targeting aberrant RNA splicing inhematological malignancies.
  • Since 2005, the Japanese Cancer Association (JCA) and Debiopharm have co-organized the 'JCA-Mauvernay Award'.

Madison Metals Signs Uranium Forward Sales Agreement and Creates the First Uranium-backed NFT with Lux Partners

Retrieved on: 
Friday, September 30, 2022
Engineering, Knowledge, Privacy, Lux, Partnership, Decentralized finance, Mining, Environment, Investment, KYC, Natural Resources, CEO, CSE, Isle, Financial technology, Non-fungible token, CAD, Fed, Swift, Uranium, AML, GLOBE, Blockchain, Cryptocurrency, U3O8

TORONTO, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Madison Metals Inc. (Madison or the Company) (CSE: GREN) (OTCQB: MMTLF) is pleased to announce the signing of a historic and first-of-its-kind uranium forward sales agreement with Lux Partners Ltd. (Lux).

Key Points: 
  • TORONTO, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Madison Metals Inc. (Madison or the Company) (CSE: GREN) (OTCQB: MMTLF) is pleased to announce the signing of a historic and first-of-its-kind uranium forward sales agreement with Lux Partners Ltd. (Lux).
  • Lux operates Lux Network , the first decentralized blockchain integrated with and operated by a network of regulated bank and money transmitter partners.
  • Lux Uranium NFTs are to be minted exclusively on Lux Network but will be made available on every major blockchain thanks to the Lux Standard for asset-backed NFTs.
  • Starting Oct. 15, 2022 via the Lux Market , almost anyone in the world will be able to mint Lux Uranium NFTs.

 Three dads, three feats of strength, one global mission: Trio of St. Jude fathers to swim, bike, run in St. Jude IRONMAN 70.3 Memphis triathlon benefitting St. Jude Children’s Research Hospital

Retrieved on: 
Friday, September 30, 2022
Men, Sports, Philanthropy, Family, Oncology, Consumer, Other Sports, Hospitals, Fund Raising, Foundation, Children, Other Philanthropy, Health, NCI-designated Cancer Center, Athlete, Child, Human, Twitter, Love, Hospital, Hope, Creativity, LinkedIn, National Cancer Institute, Pressure, ALSAC, Survival, Patient, Father, Cancer, Leukemia, Travel, CEO, Instagram, IRONMAN, Bone marrow, CT, Acute lymphoblastic leukemia, Food, TikTok, AML, Shelby Farms, Ottawa Race Weekend, ST, Biopsy, Brain, Medulloblastoma, Sierra, Housing, Dietary supplement, Nightclub, Medical imaging, Jude the Apostle, Facebook

Then, during treatment, doctors at St. Jude diagnosed him with AML, another form of leukemia in bone marrow.

Key Points: 
  • Then, during treatment, doctors at St. Jude diagnosed him with AML, another form of leukemia in bone marrow.
  • St. Jude Childrens Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases.
  • Visit St. Jude Inspire to discover powerful St. Jude stories of hope, strength, love and kindness.
  • Join the St. Jude mission by visiting stjude.org , liking St. Jude on Facebook , following St. Jude on Twitter , Instagram , LinkedIn and TikTok , and subscribing to its YouTube channel.

Pacylex Pharmaceuticals Announces Progress on Early Phase Clinical Trials of PCLX-001 in Patients

Retrieved on: 
Thursday, September 29, 2022
Apoptosis, BC Cancer Agency, Blood, Safety, Trial of the century, Exposition, Research, CHUM, Breast cancer, Breast Cancer Research and Treatment, Society, ASH, American Association, Treatment, Environment, Survival, Patient, Leukemia, NMT, Princess Margaret Hospital, CEO, Protein, Silver, Toxic leukoencephalopathy, Nature Communications, Lung, AML, Association, University, Lymphoma, Cell death, DLBCL, Pharmaceutical industry, Cancer

Edmonton, Alberta--(Newsfile Corp. - September 29, 2022) - Pacylex Pharmaceuticals has dosed 16 patients in the early phase clinical trials of the company's new cancer drug, PCLX-001.

Key Points: 
  • Edmonton, Alberta--(Newsfile Corp. - September 29, 2022) - Pacylex Pharmaceuticals has dosed 16 patients in the early phase clinical trials of the company's new cancer drug, PCLX-001.
  • In December 2021, Pacylex announced the results of the first patients dosed with PCLX-001 at the American Society of Hematology (ASH) Annual meeting and Exposition.
  • Pacylex has safely completed 4 dose cohorts reaching target drug exposure levels in patients expected to provide benefit in leukemia and lymphoma.
  • Pacylex began clinical studies of the drug in Canada in September 2021 and is currently seeking funds for Phase 2 of clinical trials.

Crypto Market Integrity Coalition Welcomes Eight New Members, including Bittrex and BitGo

Retrieved on: 
Thursday, September 29, 2022
Technology, Finance, Banking, Other Technology, Professional Services, Digital Cash Management, Digital Assets, Internet, Cryptocurrency, Other Professional Services, Crypto, Bitcoin, Tokenomy, Science, Government, Gaps, FINRA, Trust, CFTC, NFT, CMIC, BitGo, Wall Street, Darknet market, Compliance, Growth, Tokyo Pro Market, Money services business, Decentralized finance, Industry, Financial Crimes Enforcement Network, VAF, MPC, Risk management, U.S. Securities and Exchange Commission, Solution, Science and technology in Asia, Appetite, Uncertainty, Ecosystem, Cryptocurrency, CAAS, CCSS, Human, Lei, AML, Defi, SEC, TSS, ATS, Blockchain, Failure

The Crypto Market Integrity Coalition (CMIC), an industry-defining pledge focused on cultivating safer digital asset markets, announces today the addition of 8 new notable signatories.

Key Points: 
  • The Crypto Market Integrity Coalition (CMIC), an industry-defining pledge focused on cultivating safer digital asset markets, announces today the addition of 8 new notable signatories.
  • The growth of CMIC showcases the crypto industrys commitment to advancing market integrity in the digital asset space.
  • Bittrexs mission is to help advance the blockchain industry by fostering innovation, incubating new and emerging technologies, and driving transformative change.
  • The coalition takes on initiatives that promote market integrity, address gaps identified by its signatories, and further engagement with regulators.

Sumsub launches a KYT solution offering 300+ risk scenarios for transaction monitoring and fraud prevention for businesses

Retrieved on: 
Thursday, September 29, 2022
Failure, KYC, AML, HSBC Bank, New York State Department of Financial Services, CTO, Compliance, View, Risk management, KYT, Deutsche Bank, STR, Multimedia, FCA, Fraud, Financial services, Cryptocurrency, Online shopping

MIAMI, Sept. 29, 2022 /PRNewswire/ -- Sumsub, a global tech company fighting digital fraud and helping businesses stay fully compliant, is launching a KYT solution for fast and effective transaction monitoring tailored to customers' specific needs. With this new product, Sumsub can offer clients a full-cycle identity verification platform with seamless orchestration capabilities, ensuring trust along the whole user journey.

Key Points: 
  • MIAMI, Sept. 29, 2022 /PRNewswire/ -- Sumsub, a global tech company fighting digital fraud and helping businesses stay fully compliant, is launching a KYT solution for fast and effective transaction monitoring tailored to customers' specific needs.
  • Know-your-transaction (KYT), known as transaction monitoring, is a set of procedures aimed at detecting suspicious customer activity.
  • Unlike other digital verification providers, Sumsub is the only platform offering over 300 ready-to-use risk scenarios, while also enabling companies to create custom rules and risk profiles.
  • Sumsub is now offering an end-to-end orchestration solution that covers each step of the customer lifecycle, including onboarding, authentication, confirmation of risky actions, transaction monitoring.